P667: LONG-TERM EFFICACY OF ACALABRUTINIB-BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND HIGHER-RISK GENOMIC FEATURES: POOLED ANALYSIS OF CLINICAL TRIAL DATA. (23rd June 2022) - Davids, M.; Sharman, J.; Ghia, P.; Woyach, J.; Jurczak, W.; Siddiqi, T.; Miranda, P.; Shahkarami, M.; Yu, T.; Emeribe, U.; Byrd, J.